• 不 限
  • 期刊论文
  • 硕博论文
  • 会议论文
  • 报 纸
  • 英文论文
  2. 您的位置
  3. 首页
  4. 会议论文
  5. Long-term outcomes after nucleos (t) ide analogues discontinuation in HBeAg-negative chronic hepatit

Long-term outcomes after nucleos (t) ide analogues discontinuation in HBeAg-negative chronic hepatit

来源 :中华医学会第十六次全国病毒性肝炎及肝病学术会议 | 被引量 : 0次 | 上传用户：iou820915
【摘 要】
：
Background HBeAg-negative chronic hepatitis B (CHB) patients have active liver disease with a high risk of progression to decompensated cirrhosis and hepatocellular carcinoma.The management strategy o
【作 者】
：
Dengming He Yuming Wang Wen Chen Xianli Chen Guohua Yan Jie Wang Maoshi Li Shimin Guo Peng Zhu Hongfei Huang 
【机 构】
：
Institute of Infectious Diseases, Southwest Hospital, Third Military Medical University;Liver Diseas
【出 处】
：
中华医学会第十六次全国病毒性肝炎及肝病学术会议
【发表日期】
：
2013年7期
下载到本地 , 更方便阅读
下载此文 赞助VIP
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Background HBeAg-negative chronic hepatitis B (CHB) patients have active liver disease with a high risk of progression to decompensated cirrhosis and hepatocellular carcinoma.The management strategy of chronic hepatitis B with HBeAg-negative for patients treated with nucleos (t) ide analogues (NUCs) is a topic of concern.To observe the outcomes after NUCs withdrawal, HBeAg-negative CHB patients with achieving HBsAg loss or sustained undetectable HBV DNA levels and discontinued NUCs therapy were included in the study.
其他文献
The effect of granulocyte colony stimulating factor on liver injury in rats with D-galactosamine-ind
Objective To evaluate the effect of recombinant human granulocyte colony stimulating factor (rhG-CSF) on acute liver failure (ALF) induced by D-galactosamine (D-GalN) in rats.Methods The acute liver f
会议
Osteopontin (OPN) over-expression in hepatocellular carcinoma (HCC) and its clinical significance
Aim To study the expressions of OPN mRNA and protein in HCC tissue and its relationship to the clinicopathological variables.Methods Fresh resected HCC specimens and relative para-carcinoma tissues fr
会议
Study of Surgical Outcomes after Liver Resection and Chromosomal Segments Copy Number Alterations of
Background Hepatocellular carcinoma (HCC) is one of the most common malignant tumors.This particular type of carcinoma has poor survival rate and high post operation recurrence rate.Multiple factors a
会议
MicroRNA-377 as a Novel Therapy for Treatment of myocardial infarction by Regulating VEGF-mediated A
Background Vascular endothelial growth factor (VEGF) is an important signaling protein involved in both vasculogenesis (de novo formation of embryonic circulatory system) and angiogenesis (growth of b
会议
FOXG1 promote HCC stem cell self-renewal through promoting b-catenin nuclear accumulating by forming
Background Forkhead box G1 (FOXG1) is a member of Fox transcription factors family involved in the regulation of stem cell.However, the role of FOXG1 in hepatocellular carcinogenesis (HCC) is largely
会议
Interferon-b Gene Modified Human Bone Marrow Mesenchymal Stem Cells Attenuate Hepatocellular Carcino
Objective This study aim is to investigate using of bone marrow mesenchymal stem cells (BMSC) genetically engineered to produce interferon-b (IFN-b) as a gene delivery system to treat hepatocellular c
会议
血清IL-1RA水平与非酒精性脂肪性肝病的相关性及无创诊断研究
目的 非酒精性脂肪性肝病(NAFLD)尤其是其关键阶段非酒精性脂肪性肝炎(NASH)已成为全球最重要的公共健康问题之一.病理检查是NASH诊断的"金标准",但属有创诊断,不被患者接受.无创诊断是NASH诊治的必然发展方向,但目前缺乏令人满意的无创诊断、预测NASH指标.本研究探究血清白介素-1受体拮抗剂(IL-1RA)与NAFLD进展的相关性,无创性预测诊断NASH.方法 选取确诊NAFLD病例6
会议
Experimental research on the effect of RNA interference specific for Smad3 gene on the activated hep
Objective To construct an eukaryotic expression vector of RNA interference specific for Smad3, and to evaluate the effect of this siRNA on hepatic stellate cells in vitro.Methods To design psilencer3.
会议
The changes of serum I-FABP, MLT and GAS levels in the rats with acute liver failure and its' s
Object To observe the levels of serum I-FABP, MLT, GAS of the acute liver failure rats and to analysis the relationship between these indicators and gastrointestinal dysfunction of these rats, and pro
会议
Rescue therapy for HBeAg-positive chronic hepatitis B patients with resistance to lamivudine plus ad
Objective Patients who have not obtained the effective suppression of HBV cannot have an improvement in liver histology.The combination antiviral therapy of lamivudine plus adefovir is the recommended
会议